Monsanto’s ghostwriting and
strong-arming threaten sound science—and society
While
passing a placard of contemporary protest buttons in New York's Greenwich
Village, my attention was drawn to one that read "Science is Peer
Reviewed, Not Politician Approved."
This
short aphorism brought into focus two unfortunate realities. First, there are
growing segments of the population who have lost confidence in science and
choose to act on un-scientific or pseudo-scientific truth claims.
And second, other segments of the population view scientists as just another stakeholder group subject to the same market influences in the competition for producing credible knowledge.
And second, other segments of the population view scientists as just another stakeholder group subject to the same market influences in the competition for producing credible knowledge.
As
a generator of truth claims, science stands on its own footing. Unfortunately,
many corporations view science not as a generator of truth, but as one of many
inputs into production.
The
most recent examples of the corporate capture of science can be found in the
investigations of discovery documents, released under court mandate, arising
from mass tort product liability litigation filed against Monsanto Co.
Thousands of people have filed lawsuits claiming they developed cancer after exposure to the company's Roundup herbicide, and that the company suppressed information about the toxic effects of Roundup.
Thousands of people have filed lawsuits claiming they developed cancer after exposure to the company's Roundup herbicide, and that the company suppressed information about the toxic effects of Roundup.
Thousands
of pages of these discovery documents – made up largely of internal Monsanto
communications - were analyzed in two peer-reviewed publications.
My co-author Carey Gillam and I published our results in the Journal of Public Health Policy. Leemon McHenry, a member of the Philosophy Department at California State University, published his assessment in the International Journal of Risk & Safety in Medicine.
My co-author Carey Gillam and I published our results in the Journal of Public Health Policy. Leemon McHenry, a member of the Philosophy Department at California State University, published his assessment in the International Journal of Risk & Safety in Medicine.
Ghostwriting
Gillam
and I found three major trends illustrating one corporation's view of science,
scholarly journals, and environmental regulatory agencies.
Our
first finding showed that when the scientific literature did not yield the
results Monsanto desired, the company talked internally about writing its own
journal articles and paying outside scientists to list their names on the
documents when they were sent for publication.
The
procedure is called "ghostwriting" to signify that the name of the
person actually writing the study does not appear in the published article.
What is evident from the internal documents is that "ghostwriting,"
largely disavowed by respected journals as a form of plagiarism, appears as a
normal business practice for Monsanto.
Papers
showing ghostwriting practices, and/or referred to as having been ghostwritten
in internal Monsanto documents, were published in peer-reviewed journals and
concluded that there were no health concerns associated with Monsanto's
herbicide.
We
found evidence that while the papers were presented as independent – indeed, in
at least one case, a series of papers were titled as "independent" –
Monsanto employees were involved in writing, drafting and determining
conclusions.
Publication
pressure
A
second finding shared in our article is that the company used all of its
influence to pressure a journal editor to retract a paper, against the wishes
of its authors, that drew results Monsanto found disagreeable. The internal
documents describe Monsanto employee efforts to engage with the journal, making
it clear that they do not want their role to be known.
Initially,
one journal editor followed good publishing practices by supporting a
scientific debate over the paper's methods and results in the pages of the
journal. After the journal appointed a former employee of Monsanto on its
editorial board, the paper was retracted.
The
editor-in-chief wrote in the retraction statement that he found "no
evidence of fraud of intentional misrepresentation of the data," …the
results were not incorrect," and there was no misconduct. He retracted the
paper because he found the results to be "inconclusive."
Reaching
regulators
The
third illustration of corporate malfeasance was Monsanto's effort to exercise
influence over the Environmental Protection Agency to persuade another agency,
the Agency for Toxic Substances and Disease Registry, a toxicological arm of
the Department of Health and Human Services, from carrying out its own
assessment of glyphosate, the active ingredient in Roundup.
We
also learned that journals who learned from the disclosure documents that they
published ghosted papers took no action against the authors, allowing the
plagiarized papers to remain in the archival literature, even despite formal
requests for clarifications or retractions in at least one case.
"Our
society must support firewalls"
McHenry's
paper expands on the ghostwriting findings by describing a Monsanto drafted
paper for Forbes Magazine, with Henry Miller as author.
The
paper, titled "March Madness from the United Nations," disputed
findings from the International Agency for Cancer Research (IARC). In 2015 the
IARC found that the active ingredient in Roundup and many other
herbicides—glyphosate—is a probable human carcinogen and has been associated
with cases of non-Hodgkin's lymphoma.
When Forbes learned
about the ghostwriting, it had the good sense of removing the paper.
Another
of McHenry's findings from the discovery documents shows how Monsanto has
blurred the sector boundaries of a private corporation and a public university.
Monsanto supported a website at the University of Illinois at Urban-Champagne to enable two so-called "independent" faculty to do its bidding in criticizing the IARC's cancer review.
Monsanto supported a website at the University of Illinois at Urban-Champagne to enable two so-called "independent" faculty to do its bidding in criticizing the IARC's cancer review.
The
documents show that Monsanto wished to be a silent partner in this venture so
as not to discredit the reviews.
McHenry
shows us the efforts taken by Monsanto to exercise control over the
"scientific" message about its chemical herbicide.
He sums up the corporate mindset: "On one hand, [Monsanto] represents itself publicly as a vigorous champion of science against myths, fanaticism, emotion, politics and any failure to consider the total weight of evidence and, on the other, it privately seeks to protect itself against possible refutation by secretly controlling the scientific process…"
He sums up the corporate mindset: "On one hand, [Monsanto] represents itself publicly as a vigorous champion of science against myths, fanaticism, emotion, politics and any failure to consider the total weight of evidence and, on the other, it privately seeks to protect itself against possible refutation by secretly controlling the scientific process…"
To
protect the scientific enterprise, one of the core pillars of a modern
democratic society, against the forces that would turn it into the handmaiden
of industry or politics our society must support firewalls between academic
science and the corporate sectors and educate young scientists and journal
editors on the moral principles behind their respective professional roles.
Perhaps
the protest button should read: "Science is Peer Reviewed, Not Corporate
Imbued."
Related: The Monsanto Papers, Part 1 — Operation: Intoxication
The Monsanto Papers, Part 2 — Reaping a bitter harvest
Related: The Monsanto Papers, Part 1 — Operation: Intoxication
The Monsanto Papers, Part 2 — Reaping a bitter harvest
Sheldon
Krimsky is a Lenore Stern Professor of Humanities & Social Sciences and
Adjunct Professor of Public Policy & Community Medicine at Tufts
University.